Can I read DNA Ploidy, S Phase Fraction and G2 Fraction as Prognostic Determinants in Prostatic Adenocarcinoma on EtoBox?

DNA Ploidy, S Phase Fraction and G2 Fraction as Prognostic Determinants in Prostatic Adenocarcinoma by Matti Eskelinen; Pertti Lipponen; Riika Majapuro; Kari Syrjänen; Stig Nordling is a Medicine article available to read on EtoBox.

What is DNA Ploidy, S Phase Fraction and G2 Fraction as Prognostic Determinants in Prostatic Adenocarcinoma about?

The results of DNA flow cytometry (FCM), histological features and clinical stage of prostatic adenocarcinoma were correlated to outcome in 91 patients during a mean follow-up period of 15.6 years. Aneuploidy was detected in 33 (36%) tumours, and 59 (64%) tumours were diploid. Eighteen (20%) tumours showed a tetraploid DNA index. The frequency of tetraploidy increased towards high-stage and high-grade tumours. Aneuploidy, high S phase fraction (SPF) and G2 fraction were significantly related to clinical stage, histological grade and perineural infiltration. Progressing tumours (T category) had higher SPF values (p = 0.0248), and progression in N (p = 0.0122) and M categories (p = 0.0021) was related to high G2 fraction as well. In T1-2 tumours, DNA ploidy (p = 0.0280) and SPF (p = 0.0230) predicted progression, whereas histological grade had no significant predictive value. The clinical stage (T) predicted crude survival (p = 0.0005). Results show that FCM gives prognostic information in prostatic adenocarcinoma beyond that of histological grading.

Who reads DNA Ploidy, S Phase Fraction and G2 Fraction as Prognostic Determinants in Prostatic Adenocarcinoma?

Author

Matti Eskelinen; Pertti Lipponen; Riika Majapuro; Kari Syrjänen; Stig Nordling

Publisher

Elsevier Science; Elsevier ; Elsevier BV (ISSN 0302-2838)

Published

1990

Language

EN

Field

Medicine (Health Sciences)